| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $123.67M | $75.62M | $0.00 | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $177.88M | $156.73M | $143.31M | $112.38M | $72.88M |
| R&D | $141.50M | $121.56M | $111.27M | $85.06M | $57.16M |
| SG&A | $36.38M | $35.17M | $32.04M | $27.32M | $15.73M |
| Operating Income | -$54.21M | -$81.11M | -$143.31M | -$112.38M | -$72.88M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | -$1.10M | $2.57M | $338.00K | $0.00 | – |
| Net Income | -$38.63M | -$72.70M | -$135.35M | -$108.50M | -$73.96M |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | $83.07M | $73.91M | $51.40M | $47.23M | $25.00M |